The prognosis of patients with early stage breast cancer has greatly improved in the past
three decades. Following the first adjuvant endocrine therapy and chemotherapy trials …

Breast cancer is the most common cause of cancer and cancer death worldwide. Although
most patients present with localized breast cancer and may be rendered disease-free with …

At the turn of this century, breast cancer ranks as the single most common female
malignancy in many geographical areas of the world. Its growing incidence frightens …

Abstract St Gallen Expert Consensus meetings update evidence on treatment of early breast
cancer every 2 years and interpret its significance for treatment of individual patients. Such …

An important challenge in the field of cancer is finding the balance between delivering
effective treatments and avoiding adverse effects and financial toxicity caused by innovative …

Results from studies of adjuvant systemic therapy for primary breast cancer accumulated
over the past 20 years have clearly established that this treatment approach improves …

PURPOSE: Physicians and patients require quantitative information on the expected
benefits of adjuvant therapy for primary breast cancer to make appropriate treatment …

The treatment of breast cancer has improved dramatically over the past century, from a
strictly surgical approach to a coordinated one, including local and systemic therapies …

PURPOSE To update the American Society of Clinical Oncology endorsement of the Cancer
Care Ontario recommendations on the Role of Patient and Disease Factors in Adjuvant …

PURPOSE The aim of this work is to update key recommendations of the ASCO guideline
adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant …